Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal Carcinoma

PURPOSE: Despite generally favorable outcomes, 15% to 25% of patients with human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma (OPSCC) will have recurrence. Current posttreatment surveillance practices rely on physical examinations and imaging and are inconsistently applied. We a...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, Barry M., Hanna, Glenn J., Posner, Marshall R., Genden, Eric M., Lautersztain, Julio, Naber, Stephen P., Del Vecchio Fitz, Catherine, Kuperwasser, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Translational Cancer Mechanisms and Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527497/
https://www.ncbi.nlm.nih.gov/pubmed/35576437
http://dx.doi.org/10.1158/1078-0432.CCR-22-0562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527497/
https://www.ncbi.nlm.nih.gov/pubmed/35576437
http://dx.doi.org/10.1158/1078-0432.CCR-22-0562

Ejemplares similares